Modal close

Hi there,

You turn to Democracy Now! for ad-free daily news you can trust. Maybe you come for our daily headlines, or our in-depth stories that expose corporate and government abuses of power. You need news that isn't being paid for by campaigns or corporations. We produce our daily news hour at a fraction of the budget of a commercial news operation—all without ads, government funding or corporate sponsorship. How? This model of news depends on your support. Right now, every new monthly sustaining donation to Democracy Now! will be tripled by a generous supporter. That means if you can give just $4 a month, Democracy Now! gets $12 today.  Pretty amazing right? If you visit us daily or weekly or even just once a month, start your monthly contribution today. Thanks so much. -Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

New AIDS Medication

Default content image
Listen
Media Options
Listen

The International AIDS Conference in Vancouver, British Columbia, Canada is wrapping up. The most hopeful news at the conference is the development of a promising new category of medications called protease inhibitors. Some believe these drugs could turn HIV into a manageable rather than deadly disease, but the medication is extremely expensive and completely out of reach for the vast majority of people living with AIDS around the world.

Related Story

Video squareStoryJun 19, 2017Advisers Resign En Masse from Trump’s HIV/AIDS Council: Trump “Simply Does Not Care” About HIV
The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Up arrowTop